RCAN2 and metabolic dysfunction-associated steatotic liver disease: As shown in Table 1 and Figure 2A, the serum RCAN2 levels were significantly higher in the NAFLD group than those in the non-NAFLD group (11.47 ± 5.42 ng/ml vs. 8.79 ± 2.85 ng/ml, p = 0.000).